Alexander Marson MD
Clinical Fellow in Medicine, Brigham and Women's Hospital
Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2326
Fax+1 415-476-9364
Dr. Marson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
Harvard Medical SchoolClass of 2010
Certifications & Licensure
CA State Medical License 2012 - 2022
MA State Medical License 2010 - 2012
Publications & Presentations
PubMed
- 3 citationsBidirectional epigenetic editing reveals hierarchies in gene regulation.Naomi M Pacalin, Zachary Steinhart, Quanming Shi, Julia A Belk, Dmytro Dorovskyi
Nature Biotechnology. 2025-03-01 - Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy.Katie Lin, Christopher Zou, Akane Hubbard, Sasha Sengelmann, Laine Goudy
Neuro-Oncology. 2025-02-25 - SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci.Christopher R Chang, Vivasvan S Vykunta, Jae Hyun J Lee, Ke Li, Clara Kochendoerfer
Nature Biotechnology. 2025-02-05
Journal Articles
- Reprogramming Human T Cell Function and Specificity with Non-Viral Genome TargetingNeil Romberg, Antoni Ribas, Michael R Lee, Ruby Yu, Gary M Kupfer, Julia Carnevale, Jonathan H Esensten, P Jonathan Li, Han Li, Kevan C Herold, Alexander Marson, Nature
- Author Correction: Discovery of Stimulation-Responsive Immune Enhancers with CRISPR ActivationAlexander Marson, Ansuman T Satpathy, Howard Y Chang, Nature
- CRISPR/Cas9-mediated PD-1 Disruption Enhances Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T CellsAlexander Marson, MD, Nature
Press Mentions
The Long, Winding Road of Immunotherapy ResearchJune 5th, 2024- The Race to Supercharge Cancer-Fighting T CellsJanuary 25th, 2023
- Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas SymposiumOctober 7th, 2022
- Join now to see all
Grant Support
- Decoding and reprogramming T cells through synthetic biology for cancer immunotherapyJ. DAVID GLADSTONE INSTITUTES2023–2027
- Decoding and reprogramming T cells through synthetic biology for cancer immunotherapyJ. DAVID GLADSTONE INSTITUTES2023–2027
- Inherited T cell defects: Diagnosis, Mechanisms and TreatmentsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Inherited T cell defects: Diagnosis, Mechanisms and TreatmentsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Inherited T cell defects: Diagnosis, Mechanisms and TreatmentsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
